3
Announcements
Trials
Browse
Landscape
Sponsor
Interventions
Nivolumab
2
trametinib
1
selpercatinib
1
lenvatinib
1
fludarabine
1
dabrafenib
1
cemiplimab
1
aldesleukin
1
Radiotherapy, Intensity-Modulated
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Carcinoma, Anaplastic
×
tumor necrosis factor-alpha, CNGRC fusion protein, human
×
90 days
×
Clear all
No trials found.